1 - 25 of 1
Number of results to display per page
TitleDescriptionRelation Is Part OfDate
1 LEUKEMIA DRUG EFFECTIVE FOR RARE BLOOD DISEASE, U PHYSICIAN REPORTS IN THE LANCETA drug that effectively treats chronic myelogenous leukemia (CML) in two of three cases works even better against a rare but potentially fatal blood disease, a University of Utah physician reports in the prestigious British medical journal, The Lancet.Press Releases; University of Utah Health Sciences Center News2002-04-29
1 - 25 of 1